ERAS对高BMI患者是否更有益?单中心回顾性研究
该单中心回顾性研究纳入2014—2017年123例腹部游离皮瓣乳房再造患者(36例非ERAS、87例ERAS),按BMI分层评估ERAS对住院时间与并发症的影响。ERAS组住院时间更短(4.14 vs 4.69天,p=0.049),BMI越高获益越明显,且轻微并发症、重大并发症与再手术率两组相似(p>0.05)。
要点
- ERAS可安全缩短游离皮瓣乳房再造住院时间,不增加并发症风险。
- BMI越高,ERAS带来的住院时间缩短越明显。
- 轻、重并发症及再手术率在ERAS与非ERAS组间无显著差异。
核心结论
- ERAS方案用于游离皮瓣乳房再造可安全缩短住院时间,且随BMI升高获益更明显,不增加术后并发症风险。
研究设计与样本
- 单中心回顾性研究,纳入2014年1月至2017年12月行腹部游离皮瓣乳房再造的全部患者123例,其中非ERAS组36例、ERAS组87例。
主要发现
- ERAS组住院时间短于非ERAS组(4.14 vs 4.69天,p=0.049)。
- I级肥胖患者参与ERAS后住院时间减少0.99天(p=0.048),II级及以上肥胖患者减少1.35天(p=0.093)。
- ERAS与非ERAS组的轻微并发症、重大并发症及再手术率相似(p>0.05)。
关键数值与推荐
- 住院时间:ERAS组4.14天 vs 非ERAS组4.69天,p=0.049。
- I级肥胖患者住院时间减少0.99天,p=0.048;II级及以上肥胖患者减少1.35天,p=0.093。
- 轻微并发症、重大并发症及再手术率组间比较p>0.05。
临床怎么用
- 对行腹部游离皮瓣乳房再造的患者可考虑应用ERAS方案以缩短住院时间,高BMI患者可能获益更明显。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Enhanced recovery after surgery (ERAS) is increasingly used in plastic surgery to optimize patient care. Mitigating the risk of postoperative complications is particularly important in patients with risk factors, such as obesity. The objective of this study is to evaluate the impact of the ERAS pathway in patients, stratified by BMI, undergoing free flap breast reconstruction on length of stay and complications. METHODS: A retrospective review of all patients who underwent abdominally based free flap breast reconstruction from January 2014 to December 2017 was performed. Data collected include participation in the ERAS protocol, patient demographics, length of stay (LOS), complications (minor and major), and 30-day reoperation rates. RESULTS: A total of 123 patients met the inclusion criteria, with 36 non-ERAS and 87 ERAS patients. ERAS patients had a shorter length of stay than non-ERAS patients (4.14 vs. 4.69, p = 0.049). Higher BMI patients progressively benefited from their involvement in an ERAS pathway: class I obese patients had an LOS decrease of 0.99 days (p = 0.048) and class II+ obese patients had an LOS decrease of 1.35 days (p = 0.093). Minor complications, major complications, and reoperation rates were similar between ERAS and non-ERAS patients (p>0.05). CONCLUSION: Utilization of an ERAS protocol for free flap breast reconstruction safely decreases LOS, especially with increasing BMI. Patients benefit from an ERAS protocol without increasing risk of postoperative complications, compared to non-ERAS patients of similar BMIs.
引用
- Shin HD, Rodriguez AM, Abraham JT, et al. "Does ERAS benefit higher BMI patients? A single institutional review". J Plast Reconstr Aesthet Surg. 2020. PMID: 32972878. doi:10.1016/j.bjps.2020.08.098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。